Loading...
Header Logo
Keywords
Last Name
Institution

Kenneth Smith

TitleResearch Assistant Member
InstitutionOklahoma Medical Research Foundation
DepartmentArthritis and Clinical Immunology
Phone405/271-3275
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. Exploring the potential public health benefits of universal influenza vaccine. Hum Vaccin Immunother. 2019; 15(12):2919-2926. PMID: 31091166.
      View in: PubMed
    2. Nowalk MP, Wateska AR, Lin CJ, Schaffner W, Harrison LH, Zimmerman RK, Smith KJ. Racial Disparities in Adult Pneumococcal Vaccination Indications and Pneumococcal Hospitalizations in the U.S. J Natl Med Assoc. 2019 Oct; 111(5):540-545. PMID: 31171344.
      View in: PubMed
    3. Zhang Z, Gothe F, Pennamen P, James JR, McDonald D, Mata CP, Modis Y, Alazami AM, Acres M, Haller W, Bowen C, Döffinger R, Sinclair J, Brothers S, Zhang Y, Matthews HF, Naudion S, Pelluard F, Alajlan H, Yamazaki Y, Notarangelo LD, Thaventhiran JE, Engelhardt KR, Al-Mousa H, Hambleton S, Rooryck C, Smith KGC, Lenardo MJ. Human interleukin-2 receptor ß mutations associated with defects in immunity and peripheral tolerance. J Exp Med. 2019 06 03; 216(6):1311-1327. PMID: 31040185.
      View in: PubMed
    4. Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64?years compared to the US general population. Vaccine. 2019 03 28; 37(14):2026-2033. PMID: 30846259.
      View in: PubMed
    5. Wateska AR, Nowalk MP, Zimmerman RK, Smith KJ, Lin CJ. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis. BMC Infect Dis. 2018 01 25; 18(1):52. PMID: 29370768.
      View in: PubMed
    6. Shim E, Smith KJ, Nowalk MP, Raviotta JM, Brown ST, DePasse J, Zimmerman RK. Impact of seasonal influenza vaccination in the presence of vaccine interference. Vaccine. 2018 02 01; 36(6):853-858. PMID: 29329684.
      View in: PubMed
    7. Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Wateska A, France GS, Zimmerman RK. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults. Vaccine. 2017 10 09; 35(42):5708-5713. PMID: 28890196.
      View in: PubMed
    8. DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study. Vaccine. 2017 07 13; 35(32):3974-3981. PMID: 28606814.
      View in: PubMed
    9. DePasse JV, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST. Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study. Am J Epidemiol. 2017 05 01; 185(9):822-831. PMID: 28402385.
      View in: PubMed
    10. Viatte S, Lee JC, Fu B, Espéli M, Lunt M, De Wolf JN, Wheeler L, Reynolds JA, Castelino M, Symmons DP, Lyons PA, Barton A, Smith KG. Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis. Arthritis Rheumatol. 2016 11; 68(11):2629-2636. PMID: 27214848.
      View in: PubMed
    11. Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults. J Am Geriatr Soc. 2016 10; 64(10):2126-2131. PMID: 27709600.
      View in: PubMed
    12. Garman L, Smith K, Muns EE, Velte CA, Spooner CE, Munroe ME, Farris AD, Nelson MR, Engler RJ, James JA. Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination. Clin Vaccine Immunol. 2016 08; 23(8):664-71. PMID: 27280620.
      View in: PubMed
    13. Smith K, Shah H, Muther JJ, Duke AL, Haley K, James JA. Antigen nature and complexity influence human antibody light chain usage and specificity. Vaccine. 2016 05 27; 34(25):2813-20. PMID: 27113164.
      View in: PubMed
    14. Shim E, Brown ST, DePasse J, Nowalk MP, Raviotta JM, Smith KJ, Zimmerman RK. Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine. Am J Prev Med. 2016 09; 51(3):309-17. PMID: 27079638.
      View in: PubMed
    15. Kaur K, Zheng NY, Smith K, Huang M, Li L, Pauli NT, Henry Dunand CJ, Lee JH, Morrissey M, Wu Y, Joachims ML, Munroe ME, Lau D, Qu X, Krammer F, Wrammert J, Palese P, Ahmed R, James JA, Wilson PC. High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination. PLoS One. 2015; 10(5):e0125618. PMID: 25951191.
      View in: PubMed
    16. Maier-Moore JS, Koelsch KA, Smith K, Lessard CJ, Radfar L, Lewis D, Kurien BT, Wolska N, Deshmukh U, Rasmussen A, Sivils KL, James JA, Farris AD, Scofield RH. Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis Rheumatol. 2014 Dec; 66(12):3445-56. PMID: 25199908.
      View in: PubMed
    17. Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, Wilson PC. Corrigendum: Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc. 2014 Nov 20; 9(12):2903. PMID: 25411955.
      View in: PubMed
    18. Clatworthy MR, Aronin CE, Mathews RJ, Morgan NY, Smith KG, Germain RN. Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes. Nat Med. 2014 Dec; 20(12):1458-63. PMID: 25384086.
      View in: PubMed
    19. Garman L, Smith K, Farris AD, Nelson MR, Engler RJ, James JA. Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity. Toxins (Basel). 2014 Aug 13; 6(8):2424-31. PMID: 25123559.
      View in: PubMed
    20. Li H, Zuccolo J, Kem DC, Zillner C, Lee J, Smith K, James JA, Cunningham MW, Yu X. Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. J Biol Chem. 2013 Oct 18; 288(42):30734-41. PMID: 24043632.
      View in: PubMed
    21. Smith KJ, Nowalk MP, Raymund M, Zimmerman RK. Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults. Vaccine. 2013 Aug 20; 31(37):3950-6. PMID: 23806240.
      View in: PubMed
    22. Smith K, James JA, Harley JB. Editorial for Lindop et al. "long-term Ro60 humoral autoimmunity in primary Sjögren's syndrome is maintained by rapid clonal turnover". Clin Immunol. 2013 Jul; 148(1):110-2. PMID: 23685220.
      View in: PubMed
    23. Espéli M, Clatworthy MR, Bökers S, Lawlor KE, Cutler AJ, Köntgen F, Lyons PA, Smith KG. Analysis of a wild mouse promoter variant reveals a novel role for Fc?RIIb in the control of the germinal center and autoimmunity. J Exp Med. 2012 Nov 19; 209(12):2307-19. PMID: 23109709.
      View in: PubMed
    24. Smith K, Muther JJ, Duke AL, McKee E, Zheng NY, Wilson PC, James JA. Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology. 2013 May; 218(5):745-54. PMID: 23084371.
      View in: PubMed
    25. Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, Air GM. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One. 2012; 7(7):e41895. PMID: 22848649.
      View in: PubMed
    26. Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, MacAry PA. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med. 2012 Jun 20; 4(139):139ra83. PMID: 22723463.
      View in: PubMed
    27. Smith K, Crowe SR, Garman L, Guthridge CJ, Muther JJ, McKee E, Zheng NY, Farris AD, Guthridge JM, Wilson PC, James JA. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. Vaccine. 2012 Jun 13; 30(28):4276-83. PMID: 22425791.
      View in: PubMed
    28. Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, Dekker CL, Davis MM, Wilson PC, Greenberg HB, He XS. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011 Aug; 121(8):3109-19. PMID: 21785218.
      View in: PubMed
    29. Waisberg M, Tarasenko T, Vickers BK, Scott BL, Willcocks LC, Molina-Cruz A, Pierce MA, Huang CY, Torres-Velez FJ, Smith KG, Barillas-Mury C, Miller LH, Pierce SK, Bolland S. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A. 2011 Jan 18; 108(3):1122-7. PMID: 21187399.
      View in: PubMed
    30. Smith KJ, Lee BY, Nowalk MP, Raymund M, Zimmerman RK. Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds. Vaccine. 2010 Nov 10; 28(48):7620-5. PMID: 20887828.
      View in: PubMed
    31. Lee BY, Bailey RR, Wiringa AE, Afriyie A, Wateska AR, Smith KJ, Zimmerman RK. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine. 2010 Aug 23; 28(37):5952-9. PMID: 20620168.
      View in: PubMed
    32. Lee BY, Tai JH, Bailey RR, Smith KJ, Nowalk AJ. Economics of influenza vaccine administration timing for children. Am J Manag Care. 2010 Mar; 16(3):e75-e85. PMID: 20205492.
      View in: PubMed
    33. Lee BY, Tai JH, Bailey RR, Smith KJ. The timing of influenza vaccination for older adults (65 years and older). Vaccine. 2009 Nov 23; 27(50):7110-5. PMID: 19786135.
      View in: PubMed
    34. Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS. Age, revaccination, and tolerance effects on pneumococcal vaccination strategies in the elderly: a cost-effectiveness analysis. Vaccine. 2009 May 21; 27(24):3159-64. PMID: 19446186.
      View in: PubMed
    35. Lee BY, Ercius AK, Smith KJ. A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population. Vaccine. 2009 Apr 06; 27(16):2251-7. PMID: 19428839.
      View in: PubMed
    36. Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, Wilson PC. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc. 2009; 4(3):372-84. PMID: 19247287.
      View in: PubMed
    37. Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med. 2009 Jan 16; 206(1):139-51. PMID: 19103878.
      View in: PubMed
    38. Middleton DB, Lin CJ, Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS, Fox DE. Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients. Infect Control Hosp Epidemiol. 2008 May; 29(5):385-94. PMID: 18521990.
      View in: PubMed
    39. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008 May 29; 453(7195):667-71. PMID: 18449194.
      View in: PubMed
    40. Brownlie RJ, Lawlor KE, Niederer HA, Cutler AJ, Xiang Z, Clatworthy MR, Floto RA, Greaves DR, Lyons PA, Smith KG. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med. 2008 Apr 14; 205(4):883-95. PMID: 18362174.
      View in: PubMed
    41. Smith KJ, Zimmerman RK, Lin CJ, Nowalk MP, Ko FS, McEllistrem MC, Roberts MS. Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis. Vaccine. 2008 Mar 10; 26(11):1420-31. PMID: 18272262.
      View in: PubMed
    42. Walker JA, Smith KG. CD22: an inhibitory enigma. Immunology. 2008 Mar; 123(3):314-25. PMID: 18067554.
      View in: PubMed
    43. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007 Dec; 27(6):847-59. PMID: 18055230.
      View in: PubMed
    44. Koelsch K, Zheng NY, Zhang Q, Duty A, Helms C, Mathias MD, Jared M, Smith K, Capra JD, Wilson PC. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest. 2007 Jun; 117(6):1558-65. PMID: 17510706.
      View in: PubMed
    45. Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion. 2007 Apr; 47(4):629-35. PMID: 17381621.
      View in: PubMed
    46. Casellas R, Zhang Q, Zheng NY, Mathias MD, Smith K, Wilson PC. Igkappa allelic inclusion is a consequence of receptor editing. J Exp Med. 2007 Jan 22; 204(1):153-60. PMID: 17210730.
      View in: PubMed
    47. Rodgers W, Smith K. Properties of glycolipid-enriched membrane rafts in antigen presentation. Crit Rev Immunol. 2005; 25(1):19-30. PMID: 15833081.
      View in: PubMed
    48. Lanoue A, Clatworthy MR, Smith P, Green S, Townsend MJ, Jolin HE, Smith KG, Fallon PG, McKenzie AN. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med. 2004 Dec 06; 200(11):1383-93. PMID: 15583012.
      View in: PubMed
    49. Clatworthy MR, Smith KG. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med. 2004 Mar 01; 199(5):717-23. PMID: 14981111.
      View in: PubMed
    50. Pritchard NR, Smith KG. B cell inhibitory receptors and autoimmunity. Immunology. 2003 Mar; 108(3):263-73. PMID: 12603592.
      View in: PubMed
    51. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med. 2002 Sep; 113(4):300-7. PMID: 12361816.
      View in: PubMed
    52. Rudge EU, Cutler AJ, Pritchard NR, Smith KG. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J Exp Med. 2002 Apr 15; 195(8):1079-85. PMID: 11956299.
      View in: PubMed
    Smith's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description